Teva Pharma Files 8-K
Ticker: TEVJF · Form: 8-K · Filed: May 22, 2025 · CIK: 818686
| Field | Detail |
|---|---|
| Company | Teva Pharmaceutical Industries Ltd (TEVJF) |
| Form Type | 8-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd, filing
Related Tickers: TEVA
TL;DR
Teva filed an 8-K on May 20th, expect updates.
AI Summary
Teva Pharmaceutical Industries Ltd. filed an 8-K on May 22, 2025, reporting events as of May 20, 2025. The filing indicates disclosures related to Regulation FD, other events, and financial statements and exhibits. Specific details regarding the nature of these events or any financial figures were not provided in the excerpt.
Why It Matters
This 8-K filing signals that Teva Pharmaceutical Industries Ltd. has made significant disclosures to the SEC, potentially impacting investor understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and does not contain specific negative or positive financial news in the provided text.
Key Players & Entities
- TEVA PHARMACEUTICAL INDUSTRIES LTD (company) — Registrant
- May 20, 2025 (date) — Date of earliest event reported
- May 22, 2025 (date) — Date of Report
FAQ
What specific events are being disclosed under Regulation FD?
The provided excerpt does not specify the details of the Regulation FD disclosure.
Are there any new financial statements or exhibits attached to this filing?
The filing indicates that financial statements and exhibits are included, but their content is not detailed in the excerpt.
What is the significance of the 'Other Events' item?
The excerpt does not provide information on what constitutes the 'Other Events' for Teva Pharmaceutical Industries Ltd.
What is Teva Pharmaceutical Industries Ltd.'s principal executive office address?
Teva Pharmaceutical Industries Ltd.'s principal executive office is located at 124 Dvora HaNevi’a Street, Tel Aviv 6944020, Israel.
What is the Commission File Number for Teva Pharmaceutical Industries Ltd.?
The Commission File Number for Teva Pharmaceutical Industries Ltd. is 001-16174.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF).